301 related articles for article (PubMed ID: 33116140)
21. TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities.
Garcia K; Gingras AC; Harvey KF; Tanas MR
Trends Cancer; 2022 Dec; 8(12):1033-1045. PubMed ID: 36096997
[TBL] [Abstract][Full Text] [Related]
22. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
[TBL] [Abstract][Full Text] [Related]
23. Mechanosensitive transcriptional coactivators MRTF-A and YAP/TAZ regulate nucleus pulposus cell phenotype through cell shape.
Fearing BV; Jing L; Barcellona MN; Witte SE; Buchowski JM; Zebala LP; Kelly MP; Luhmann S; Gupta MC; Pathak A; Setton LA
FASEB J; 2019 Dec; 33(12):14022-14035. PubMed ID: 31638828
[TBL] [Abstract][Full Text] [Related]
24. YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility.
Mason DE; Collins JM; Dawahare JH; Nguyen TD; Lin Y; Voytik-Harbin SL; Zorlutuna P; Yoder MC; Boerckel JD
J Cell Biol; 2019 Apr; 218(4):1369-1389. PubMed ID: 30737263
[TBL] [Abstract][Full Text] [Related]
25. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
[No Abstract] [Full Text] [Related]
26. YAP-dependent Wnt5a induction in hypertrophic adipocytes restrains adiposity.
Lee GJ; Kim YJ; Park B; Yim S; Park C; Roh H; Moon Y; Seong JK; Park H
Cell Death Dis; 2022 Apr; 13(4):407. PubMed ID: 35478181
[TBL] [Abstract][Full Text] [Related]
27. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
28. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
29. Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ.
Xekouki P; Lodge EJ; Matschke J; Santambrogio A; Apps JR; Sharif A; Jacques TS; Aylwin S; Prevot V; Li R; Flitsch J; Bornstein SR; Theodoropoulou M; Andoniadou CL
Endocr Relat Cancer; 2019 Jan; 26(1):215-225. PubMed ID: 30139767
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
[TBL] [Abstract][Full Text] [Related]
32. YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.
Li H; Singh A; Perkumas KM; Stamer WD; Ganapathy PS; Herberg S
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):15. PubMed ID: 36350617
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q
Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167
[TBL] [Abstract][Full Text] [Related]
34. HMGB2 orchestrates mitotic clonal expansion by binding to the promoter of C/EBPβ to facilitate adipogenesis.
Chen K; Zhang J; Liang F; Zhu Q; Cai S; Tong X; He Z; Liu X; Chen Y; Mo D
Cell Death Dis; 2021 Jul; 12(7):666. PubMed ID: 34215724
[TBL] [Abstract][Full Text] [Related]
35. Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
Gao Y; Chen X; He Q; Gimple RC; Liao Y; Wang L; Wu R; Xie Q; Rich JN; Shen K; Yuan Z
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33295-33304. PubMed ID: 33318171
[TBL] [Abstract][Full Text] [Related]
36. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
[TBL] [Abstract][Full Text] [Related]
37. Human adipocyte function is impacted by mechanical cues.
Pellegrinelli V; Heuvingh J; du Roure O; Rouault C; Devulder A; Klein C; Lacasa M; Clément E; Lacasa D; Clément K
J Pathol; 2014 Jun; 233(2):183-95. PubMed ID: 24623048
[TBL] [Abstract][Full Text] [Related]
38. Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury.
Gabdulkhakova A; Krutsenko Y; Zhu J; Liu S; Poddar M; Singh S; Ma X; Nejak-Bowen K; Monga SPS; Molina LM
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556373
[TBL] [Abstract][Full Text] [Related]
39. CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.
Wang S; Englund E; Kjellman P; Li Z; Ahnlide JK; Rodriguez-Cupello C; Saggioro M; Kanzaki R; Pietras K; Lindgren D; Axelson H; Prinz CN; Swaminathan V; Madsen CD
Nat Cell Biol; 2021 Jul; 23(7):758-770. PubMed ID: 34226698
[TBL] [Abstract][Full Text] [Related]
40. YAP and TAZ regulate cell volume.
Perez-Gonzalez NA; Rochman ND; Yao K; Tao J; Le MT; Flanary S; Sablich L; Toler B; Crentsil E; Takaesu F; Lambrus B; Huang J; Fu V; Chengappa P; Jones TM; Holland AJ; An S; Wirtz D; Petrie RJ; Guan KL; Sun SX
J Cell Biol; 2019 Oct; 218(10):3472-3488. PubMed ID: 31481532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
